JAK1 and neoplasm: To be able to examine the role of tumor-intrinsic IFN-γ signaling in the antitumor immune response in vivo, we generated IFNγR2- and Jak1-mutant B16.SIY tumor cell lines by single-cell cloning using the sgRNAs identified from the CRISPR/Cas9 screen.